Molecular targets and regulators of cardiac hypertrophy-Reference-Cited by-同舟云学术

Molecular targets and regulators of cardiac hypertrophy

Published:2010-04 Issue:4 Volume:61 Page:269-280
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Rohini Agrawal,Agrawal Neeraj,Koyani Chintan N.,Singh Randhir

Publisher

Elsevier BV

Subject

Pharmacology

Reference162 articles.

1. Hypertrophy of the heart: a new therapeutic target?;Frey;Circulation,2004

2. Prognosis implications of echocardiographically determined left ventricluar mass in the Framingham Heart Study;Levy;N Engl J Med,1990

3. Assessment of the coronary artery disease and systolic dysfunction in hypertensive patients with the dobutamine-atropine stress echocardiography effect of the left ventricular hypertrophy;Ho;Cardiology,1998

4. Phenotyping hypertrophy: eschew obfuscation;Dorn;Circ Res,2003

5. Risk of death associated with nesiritide in patients with acutely decompensated heart failure;Aaronson;J Am Med Assoc,2006

Cited by 251 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baicalin ameliorates angiotensin II-induced cardiac hypertrophy and mitogen-activated protein kinase signaling pathway activation: A target-based network pharmacology approach;European Journal of Pharmacology;2024-10

2. MAS RECEPTOR BLOCKADE IMPAIRS EXERCISE-INDUCED CARDIAC HYPERTROPHY;Peptides;2024-09

3. Prospects for the Use of Cell Cultures in Modeling Myocardial Diseases: Hypertrophic Cardiomyopathy;Cell and Tissue Biology;2024-08

4. Identification of immune-related genes and small-molecule drugs in hypertension-induced left ventricular hypertrophy based on machine learning algorithms and molecular docking;Frontiers in Immunology;2024-06-27

5. Development of the cardioprotective drugs class based on pathophysiology of myocardial infarction: A comprehensive review;Current Problems in Cardiology;2024-05